Literature DB >> 28404666

Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study.

René Höhn1,2, Alireza Mirshahi1,3, Stefan Nickels1, Andreas Schulz4, Philipp S Wild4,5,6, Maria Blettner7, Norbert Pfeiffer1.   

Abstract

BACKGROUND: Intraocular pressure (IOP) is well known to be associated with blood pressure and other cardiovascular risk factors. The influence of systemic cardiovascular, in particular antihypertensive, medication on IOP is still controversial. This study analyses the association between the use of cardiovascular medications and IOP in a large European cohort.
METHODS: The Gutenberg Health Study is a population-based, prospective,observational cohort study in mid-western Germany. IOP was measured using a non-contact tonometer. The medication classes examined were peripheral vasodilators, diuretics, β-blockers (overall, selective and non-selective), calcium channel blockers, renin-angiotensin blockers (overall, ACE inhibitors and angiotensin-receptor blockers), nitrates, other antihypertensive medications, aspirin and statins. Subjects with missing IOP values, topical IOP-lowering medication or previous ocular surgery were excluded. In total, 13 527 subjects were enrolled in this study. Association analyses between medication use and IOP were performed using multivariable linear regression (p<0.0038).
RESULTS: Neither selective nor non-selective systemic β-blocker intake was associated with statistically significant lower IOP (-0.12 mm Hg, p=0.054 and -0.70 mm Hg, p=0.037, respectively). IOP was not associated with the use of ACE inhibitors after adjustment for body mass index, systolic blood pressure and central corneal thickness (0.11 mm Hg; p=0.07).
CONCLUSIONS: None of the cardiovascular medications, in particular systemic β-blocking agents, showed an association with IOP in non-glaucoma subjects. The long-term drift phenomenon of topical and systemic β-blocker might explain this result. Our results suggest that systemic β-blockers have a negligible effect on IOP reduction. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Intraocular pressure; beta-blocker; cardiovascular medication; long-term drift; population-based cohort

Mesh:

Substances:

Year:  2017        PMID: 28404666     DOI: 10.1136/bjophthalmol-2016-309993

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

Review 1.  Management of Blood Pressure in Patients with Glaucoma.

Authors:  Russell M Levine; Alina Yang; Venkatesh Brahma; James F Martone
Journal:  Curr Cardiol Rep       Date:  2017-09-19       Impact factor: 2.931

2.  Local ocular renin-angiotensin-aldosterone system: any connection with intraocular pressure? A comprehensive review.

Authors:  Mervi Holappa; Heikki Vapaatalo; Anu Vaajanen
Journal:  Ann Med       Date:  2020-04-30       Impact factor: 4.709

3.  Outcome After Selective Laser Trabeculoplasty for Glaucoma Treatment in a Thai Population.

Authors:  Panrapee Funarunart; Isaraporn Treesit
Journal:  Clin Ophthalmol       Date:  2021-03-18

4.  Statin Use in Relation to Intraocular Pressure, Glaucoma, and Ocular Coherence Tomography Parameters in the UK Biobank.

Authors:  Jihye Kim; Marianne T Kennedy Neary; Hugues Aschard; Mathew M Palakkamanil; Ron Do; Janey L Wiggs; Anthony P Khawaja; Louis R Pasquale; Jae H Kang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-05-02       Impact factor: 4.925

Review 5.  A review of systemic medications that may modulate the risk of glaucoma.

Authors:  Annie Wu; Anthony P Khawaja; Louis R Pasquale; Joshua D Stein
Journal:  Eye (Lond)       Date:  2019-10-08       Impact factor: 3.775

6.  Comparative analysis of cytokine profiles of glaucomatous tears and aqueous humour reveals potential biomarkers for trabeculectomy complications.

Authors:  Éva Csősz; Eszter Deák; Noémi Tóth; Carlo Enrico Traverso; Adrienne Csutak; József Tőzsér
Journal:  FEBS Open Bio       Date:  2019-04-23       Impact factor: 2.693

7.  Associations of statin use with the onset and progression of open-angle glaucoma: A systematic review and meta-analysis.

Authors:  Yixiong Yuan; Ruilin Xiong; Yi Wu; Jason Ha; Wei Wang; Xiaotong Han; Mingguang He
Journal:  EClinicalMedicine       Date:  2022-04-05

8.  Distribution of Pupil Size and Associated Factors: Results from the Population-Based Gutenberg Health Study.

Authors:  Marian Kiel; Stephanie D Grabitz; Susanne Hopf; Thomas Koeck; Philipp S Wild; Irene Schmidtmann; Karl J Lackner; Thomas Münzel; Manfred E Beutel; Norbert Pfeiffer; Alexander K Schuster
Journal:  J Ophthalmol       Date:  2022-09-09       Impact factor: 1.974

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.